Respiratory

Xpert MTB/RIF Ultra is able to enhance tuberculosis diagnosis and stratify transmission risk, offering a powerful tool for clinicians.

With traditional bronchial provocation tests often inaccessible in clinical settings, this predictive nomogram offers a practical alternative to assist clinicians.

The Prospector calculator reduces antibiotic use by nearly half in COPD exacerbations, showing promise for safer and more effective patient care.

A high blood NMLR is linked to increased 5-year mortality in COPD patients, highlighting its role as a key prognostic tool.

Home high-flow therapy improves recovery for COPD patients after severe exacerbations, showing potential for better symptom control and reduced readmissions.

A recent outbreak in India identified new hMPV strains, A2.2.1 and A2.2.2, highlighting the evolving threat of paediatric respiratory infections.

Combined valve implantation in the right upper and middle lobes shows promise for severe emphysema, with significant benefits for heterogeneous cases.

1 in 28 people globally will develop lung cancer, with men and wealthy nations at greatest risk, highlighting urgent healthcare disparities.